BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 288 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $299,669,921 | -20.0% | 5,967,143 | +0.6% | 0.01% | -22.2% |
Q2 2023 | $374,739,786 | +41.7% | 5,929,427 | +0.9% | 0.01% | +28.6% |
Q1 2023 | $264,493,691 | +4.6% | 5,878,944 | +1.8% | 0.01% | 0.0% |
Q4 2022 | $252,978,917 | -32.2% | 5,774,456 | +2.0% | 0.01% | -36.4% |
Q3 2022 | $373,009,000 | +31.5% | 5,661,103 | +0.8% | 0.01% | +37.5% |
Q2 2022 | $283,706,000 | -19.6% | 5,616,811 | +1.7% | 0.01% | 0.0% |
Q1 2022 | $352,941,000 | -40.5% | 5,525,060 | -0.2% | 0.01% | -38.5% |
Q4 2021 | $592,722,000 | +3.3% | 5,533,771 | -0.9% | 0.01% | -7.1% |
Q3 2021 | $574,001,000 | +17.3% | 5,583,132 | +0.3% | 0.01% | +16.7% |
Q2 2021 | $489,544,000 | -8.7% | 5,565,543 | +0.9% | 0.01% | -20.0% |
Q1 2021 | $536,111,000 | -7.8% | 5,513,829 | +6.3% | 0.02% | -11.8% |
Q4 2020 | $581,667,000 | +30.9% | 5,186,512 | +8.2% | 0.02% | +13.3% |
Q3 2020 | $444,476,000 | +15.6% | 4,794,780 | -2.7% | 0.02% | +7.1% |
Q2 2020 | $384,479,000 | +34.8% | 4,929,210 | +1.1% | 0.01% | +16.7% |
Q1 2020 | $285,186,000 | -18.5% | 4,876,660 | +11.6% | 0.01% | 0.0% |
Q4 2019 | $349,919,000 | +9.7% | 4,367,984 | +0.6% | 0.01% | 0.0% |
Q3 2019 | $318,958,000 | -21.0% | 4,341,335 | +1.4% | 0.01% | -20.0% |
Q2 2019 | $403,861,000 | +27.4% | 4,281,362 | +8.1% | 0.02% | +25.0% |
Q1 2019 | $316,958,000 | +54.0% | 3,959,505 | +3.7% | 0.01% | +33.3% |
Q4 2018 | $205,826,000 | -29.4% | 3,817,962 | +2.2% | 0.01% | -18.2% |
Q3 2018 | $291,584,000 | +26.8% | 3,735,390 | +3.1% | 0.01% | +10.0% |
Q2 2018 | $230,015,000 | -25.8% | 3,623,418 | +7.1% | 0.01% | -28.6% |
Q1 2018 | $310,134,000 | +24.0% | 3,382,055 | +2.0% | 0.01% | +27.3% |
Q4 2017 | $250,129,000 | +85.6% | 3,316,928 | +71.5% | 0.01% | +83.3% |
Q3 2017 | $134,758,000 | +87.8% | 1,934,229 | +36.6% | 0.01% | +50.0% |
Q2 2017 | $71,746,000 | +47.0% | 1,415,963 | +16.0% | 0.00% | +33.3% |
Q1 2017 | $48,806,000 | +91.8% | 1,220,446 | +34.5% | 0.00% | +200.0% |
Q4 2016 | $25,448,000 | +20.3% | 907,265 | +27.3% | 0.00% | 0.0% |
Q3 2016 | $21,161,000 | +84.3% | 712,475 | +25.7% | 0.00% | 0.0% |
Q2 2016 | $11,481,000 | +20.5% | 566,995 | +7.4% | 0.00% | 0.0% |
Q1 2016 | $9,526,000 | -28.3% | 527,742 | +4.6% | 0.00% | 0.0% |
Q4 2015 | $13,287,000 | -92.7% | 504,456 | -89.9% | 0.00% | -85.7% |
Q3 2015 | $181,709,000 | +3610.6% | 4,981,966 | +2594.8% | 0.01% | – |
Q2 2015 | $4,897,000 | – | 184,871 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
SIB LLC | 65,151 | $6,335,000 | 3.72% |
CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |